These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 6715565)
1. A controlled endoscopic study comparing the toxic effects of sulindac, naproxen, aspirin, and placebo on the gastric mucosa of health volunteers. Lanza FL; Nelson RS; Rack MF J Clin Pharmacol; 1984; 24(2-3):89-95. PubMed ID: 6715565 [TBL] [Abstract][Full Text] [Related]
2. Gastric bleeding and gastric secretion with sulindac and naproxen. Hunt JN; Smith JL; Jiang CL Dig Dis Sci; 1983 Feb; 28(2):169-73. PubMed ID: 6600677 [TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory effect of sulindac sulfoxide and sulfide on gastric mucosa. Graham DY; Smith JL; Holmes GI; Davies RO Clin Pharmacol Ther; 1985 Jul; 38(1):65-70. PubMed ID: 3874038 [TBL] [Abstract][Full Text] [Related]
4. The effects of ibuprofen, indomethacin, aspirin, naproxen, and placebo on the gastric mucosa of normal volunteers: a gastroscopic and photographic study. Lanza FL; Royer GL; Nelson RS; Chen TT; Seckman CE; Rack MF Dig Dis Sci; 1979 Nov; 24(11):823-8. PubMed ID: 520100 [TBL] [Abstract][Full Text] [Related]
5. Gastroscopic observations following aspirin and naproxen sodium administration. Halvorsen L; Sevelius H J Clin Pharmacol; 1981 Apr; 21(4):169-72. PubMed ID: 7240438 [TBL] [Abstract][Full Text] [Related]
6. Effect of Helicobacter pylori infection on the severity of gastroduodenal mucosal injury after the acute administration of naproxen or aspirin to normal volunteers. Lanza FL; Evans DG; Graham DY Am J Gastroenterol; 1991 Jun; 86(6):735-7. PubMed ID: 2038996 [TBL] [Abstract][Full Text] [Related]
7. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients. Bianchi Porro G; Lazzaroni M; Petrillo M Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319 [TBL] [Abstract][Full Text] [Related]
8. Lithium interaction with sulindac and naproxen. Ragheb M; Powell AL J Clin Psychopharmacol; 1986 Jun; 6(3):150-4. PubMed ID: 3711365 [TBL] [Abstract][Full Text] [Related]
9. Effects of fenbufen, indomethacin, naproxen, and placebo on gastric mucosa of normal volunteers. A comparative endoscopic and photographic evaluation. Lanza FL; Nelson RS; Greenberg BP Am J Med; 1983 Oct; 75(4B):75-9. PubMed ID: 6605681 [TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E2 content in residual gastric juice reflects endoscopic damage to the gastric mucosa after naproxen sodium administration. Sarosiek J; Marcinkiewicz M; Parolisi S; Peura DA Am J Gastroenterol; 1996 May; 91(5):873-8. PubMed ID: 8633574 [TBL] [Abstract][Full Text] [Related]
11. Endoscopic ulcer rates in healthy subjects associated with use of aspirin (81 mg q.d.) alone or coadministered with celecoxib or naproxen: a randomized, 1-week trial. Goldstein JL; Aisenberg J; Zakko SF; Berger MF; Dodge WE Dig Dis Sci; 2008 Mar; 53(3):647-56. PubMed ID: 17676393 [TBL] [Abstract][Full Text] [Related]
12. Ranitidine: differential effects on gastric bleeding and mucosal damage induced by aspirin. Cole AT; Brundell S; Hudson N; Hawthorne AB; Mahida YR; Hawkey CJ Aliment Pharmacol Ther; 1992 Dec; 6(6):707-15. PubMed ID: 1486156 [TBL] [Abstract][Full Text] [Related]
13. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor. Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964 [TBL] [Abstract][Full Text] [Related]
14. Alendronate and naproxen are synergistic for development of gastric ulcers. Graham DY; Malaty HM Arch Intern Med; 2001 Jan; 161(1):107-10. PubMed ID: 11146706 [TBL] [Abstract][Full Text] [Related]
15. A prospective randomized study of the injurious effects of aspirin and naproxen on the gastroduodenal mucosa in patients with rheumatoid arthritis. Mehta S; Dasarathy S; Tandon RK; Mathur M; Malaviya AN Am J Gastroenterol; 1992 Aug; 87(8):996-1000. PubMed ID: 1642224 [TBL] [Abstract][Full Text] [Related]
16. Effects of indomethacin, sulindac, naproxen, aspirin, and paracetamol in treated hypertensive patients. Chalmers JP; West MJ; Wing LM; Bune AJ; Graham JR Clin Exp Hypertens A; 1984; 6(6):1077-93. PubMed ID: 6378437 [TBL] [Abstract][Full Text] [Related]
17. The relationship between the content of aggressive and protective components in gastric juice and endoscopic findings after naproxen sodium and acetaminophen administration. Marcinkiewicz M; Peura DA; Sarosiek J Am J Gastroenterol; 1996 Feb; 91(2):360-5. PubMed ID: 8607507 [TBL] [Abstract][Full Text] [Related]
18. A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production. Laine L; Sloane R; Ferretti M; Cominelli F Gastrointest Endosc; 1995 Nov; 42(5):428-33. PubMed ID: 8566633 [TBL] [Abstract][Full Text] [Related]
19. Lack of interaction between sulindac or naproxen and propranolol in hypertensive patients. Schuna AA; Vejraska BD; Hiatt JG; Kochar M; Day R; Goodfriend TL J Clin Pharmacol; 1989 Jun; 29(6):524-8. PubMed ID: 2666452 [TBL] [Abstract][Full Text] [Related]
20. Optimal assessment of gastrointestinal side effects induced by non-steroidal anti-inflammatory drugs. Endoscopic lesions, faecal blood loss, and symptoms not necessarily correlated, as observed after naproxen and oxindanac in healthy volunteers. Aabakken L; Dybdahl JH; Eidsaunet W; Haaland A; Larsen S; Osnes M Scand J Gastroenterol; 1989 Oct; 24(8):1007-13. PubMed ID: 2688064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]